Table 1.
Baseline characteristics of HIV-infected adults at enrollment in care and treatment program in Dar es Salaam, Tanzania
| Characteristic* | N (%) |
|---|---|
| Gender | |
| Female | 32, 885 (68.4) |
| Age group, years | |
| 30 | 9,200 (19.3) |
| 30 to < 40 | 21,073 (44.2) |
| 40 to < 50 | 12,163 (25.5) |
| 50+ | 5,258 (11) |
| Marital status | |
| Married/cohabiting | 20,448 (51) |
| Widowed/divorced/separated | 64,896 (16.2) |
| Single | 13,172 (32.8) |
| District (residence) | |
| Ilala | 14,272 (29.8) |
| Kinondoni | 21,195 (44.3) |
| Temeke | 12,429 (26) |
| BMI group, kg/m2 | |
| < 18.5 | 12,524 (26.8) |
| 18.5 to < 25 | 25,461 (54.5) |
| 25.0 to < 30 | 6,295 (13.5) |
| 30+ | 2,469 (5.2) |
| WHO HIV disease stage | |
| I | 6,479 (14.1) |
| II | 9,125 (19.9) |
| III | 21,715 (47.2) |
| IV | 8,627 (18.8) |
| CD4 count, cells/μL | |
| < 50 | 8,070 (19) |
| 50 to < 200 | 16,018 (37.6) |
| 200+ | 18,464 (43.4) |
| Medical history | |
| No previous ART use | 41,324 (88.7) |
| Previous ART use | 5,263 (11.3) |
| TB history | 10,841 (24.5) |
| Illnesses (OIs) | |
| Oral candidiasis | 2,823 (6.4) |
| Diarrhea | 2,627 (5.9) |
| Kaposi's sarcoma | 278 (0.6) |
| Biochemical tests | |
| ALT > 120 U/L | 360 (1) |
| Hepatitis B surface antigen | 650 (5.9) |
| Creatinine > 1.2 mmol/L | 3,369 (15.1) |
| Medications | |
| On septrin prophylaxis | 10,987 (22.9) |
| Taking a multivitamin | 8,289 (20.7) |
| On TB treatment | 4,662 (9.7) |
| Baseline regimen contains AZT† | 12,986 (27) |
| Baseline regimen contains EFV† | 12,210 (25.2) |
| Baseline ART regimen† | |
| D4T, 3TC, NVP | 9,164 (36.7) |
| D4T, 3TC, EFV | 2,842 (11.4) |
| AZT, 3TC, NVP | 3,046 (12.2) |
| AZT, 3TC, EFV | 9,940 (39.8) |
ALT = alanine aminotransferase; ART = antiretroviral treatment; AZT = zidovudine; BMI = body mass index; D4T = stavudine; EFV = efavirenz; HIV = human immunodeficiency virus; NVP = nevirapine; OIs = opportunistic infections; TB = tuberculosis; 3TC = lamivudine; WHO = World Health Organization.
*
Totals do not add up to 48,068 due to missing values.
†
Total is sub-population of those with at least two hemoglobin measures, who initiated ART at baseline.